Research shows ability to surface real-world, regimen-specific symptom trends and highlight potential in-class differences using the Canopy Remote Therapeutic Monitoring Platform
Read more
Featured in: AJMC Evidence Based Oncology | Volume 31 | Issue 04
Read more
DH100 recognizes standout companies that have helped make New York the capital of healthcare innovation
Read more
Research Shows Potential to Improve Time on Treatment and Detection of High-Risk Toxicities for Blood Cancer Patients Using the Canopy Continuous Care Platform New York – Canopy, the first Continuous Care Platform for oncology, today announced findings from two studies demonstrating the clinical impact of EHR-integrated Remote Therapeutic Monitoring for patients with various hematologic malignancies. These studies demonstrate the potential of the Canopy Platform to increase time on treatment and improve detection of high-risk toxicities in patients across a variety of therapies, including bispecific antibodies.
Read more
Canopy, the first Continuous Care Platform for oncology, today announced the strategic expansion of its leadership team with the appointments of Josh Neiman as President and Chief Commercial Officer and Geoff Calkins as Chief Product and Strategy Officer. With these strategic appointments, Canopy is poised to strengthen its leadership position in the oncology space and deliver on its mission to provide comprehensive, continuous care solutions that empower practices and improve patient outcomes.
Read more
Facilitating the Safe Integration of Bispecific Antibodies into Community Oncology
Read more
Jan 01 2023
Nov 07 2022
Sep 06 2022
Mar 19 2022
Mar 18 2022
Mar 17 2022
Mar 17 2022
